Thromboembolic safety of transdermal hormone therapy

被引：0
|
作者：
Stachowiak, Grzegorz [1 ]
Pertynski, Tomasz [1 ]
机构：
[1] Inst Zdrowia Matki Polki W Lodzi, Klin Menopauzy & Chorob Kobiecych, PL-93338 Lodz, Poland
来源：
MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY | 2008年 / 7卷 / 06期
关键词：
menopause; transdermal hormone therapy; thromboembolic complications;
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
This article is a review of up-to-date reports-the newest references and own studies - on the influence of transdermal hormone therapy (HT) on thromboembolic risk in menopausal women. The available data testify clearly to the high thromboembolic safety of HT, even when this therapy is administered in women with thromboembolic risk factors.
引用
收藏
页码：285 / 290
页数：6
相关论文
共 50 条
  • [1] The influence of transdermal hormone therapy on thromboembolic risk of women at menopausal period
    Pertynski, Tomasz
    Stachowiak, Grzegorz
    Stetkiewicz, Tomasz
    Faflik, Urszula
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2006, 5 (02): : 92 - 95
  • [2] Comparative venous thromboembolic safety of oral and transdermal postmenopausal hormone therapies among women Veterans
    Blondon, Marc
    Timmons, Andrew K.
    Baraff, Aaron J.
    Floyd, James S.
    Harrington, Laura B.
    Korpak, Anna M.
    Smith, Nicholas L.
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2021, 28 (10): : 1125 - 1129
  • [3] Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy
    Barbara Ruszkowska
    Grażyna Gadomska
    Liliana Bielis
    Marzena Gruszka
    Barbara Góralczyk
    Danuta Rość
    Grażyna Odrowąż-Sypniewska
    Journal of Zhejiang University SCIENCE B, 2011, 12 : 12 - 17
  • [4] Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy
    Barbara RUSZKOWSKA
    GraZyna GADOMSKA
    Liliana BIELIS
    Marzena GRUSZKA
    Barbara GóRALCZYK
    Danuta RO
    GraZyna ODROWAZ-SYPNIEWSKA
    Journal of Zhejiang University-Science B(Biomedicine & Biotechnology), 2011, 12 (01) : 12 - 17
  • [5] Risk of venous thromboembolic disease in postmenopausal women taking oral or transdermal hormone replacement therapy
    Ruszkowska, Barbara
    Gadomska, Grazyna
    Bielis, Liliana
    Gruszka, Marzena
    Goralczyk, Barbara
    Rosc, Danuta
    Odrowaz-Sypniewska, Grazyna
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2011, 12 (01): : 12 - 17
  • [6] Hormone therapy and thromboembolic disease
    Battaglioli, Tullia
    Martinelli, Ida
    CURRENT OPINION IN HEMATOLOGY, 2007, 14 (05) : 488 - 493
  • [7] Safety of transdermal hormone therapy in menopausal women at increased risk for venous thromboembolism
    Sobel, Talia
    Shen, Wen
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2020, 27 (12): : 1473 - 1474
  • [8] Transdermal progestins in hormone replacement therapy
    Jasonni, VM
    Naldi, S
    Amadori, A
    Santini, D
    Ceccarelli, C
    Possati, G
    DAnna, R
    Leonardi, J
    UTERUS: ENDOMETRIUM AND MYOMETRIUM, 1997, 828 : 352 - 357
  • [9] COMBINED TRANSDERMAL HORMONE-THERAPY
    KELLER, PJ
    ADVANCES IN GYNECOLOGICAL ENDOCRINOLOGY, VOLS 1 AND 2, 1988, : 651 - 657
  • [10] Transdermal hormone therapy and bone health
    Shulman, Lee P.
    CLINICAL INTERVENTIONS IN AGING, 2008, 3 (01) : 51 - 54
12345